Latest Breaking News On - Silverstein foundation - Page 5 : comparemela.com

Acurex Biosciences to Present at the Michael J Fox Foundation Parkinson s Disease Therapeutics Conference | National Business

SAN CARLOS, Calif. (BUSINESS WIRE) Oct 10, 2023

New yorkUnited statesStanford universityAcurex biosciencesAshley gonzalezWilliam shraderTherapeutic developmentSilverstein foundationMichaelj fox foundationAcurex biosciences corporationBiosciences corporationDisease therapeutics conferenceMitophagy biomarkersConvene centerBusiness wireNational business

Acurex Biosciences to Present at the Michael J Fox Foundation Parkinson s Disease Therapeutics Conference | Region

SAN CARLOS, Calif. (BUSINESS WIRE) Oct 10, 2023

New yorkUnited statesStanford universityAshley gonzalezAcurex biosciencesWilliam shraderSilverstein foundationAcurex biosciences corporationMichaelj fox foundationTherapeutic developmentBiosciences corporationDisease therapeutics conferenceMitophagy biomarkersConvene centerBusiness wire

Gain Therapeutics Announces Dosing of First Two Subjects in Phase 1 Clinical Trial of GT-02287, a Novel GCase-targeting Small Molecule Therapy for GBA1 Parkinson s Disease

First small molecule allosteric binder discovered with Gain’s computational drug discovery platform enters clinical developmentBETHESDA, Md., Oct. 04, 2023 Gain Therapeutics, Inc. , a.

Matthias alderSusan sharpeExchange commissionSilverstein foundation for parkinsonCompany annual report on formNational gaucher foundationMichaelj fox foundation for parkinson researchTreatment initiativeLinnden communicationsExchange commission onGain therapeutics incChief executive officerRobin elyRegenerative medicineClinical scientific consultantSilverstein foundation

Gain Therapeutics to Present at the Cambridge Healthtech Institute s 2nd Annual Neurodegeneration Targets Conference

Gain Therapeutics to Present at the Cambridge Healthtech Institute s 2nd Annual Neurodegeneration Targets Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMatthias alderSusan sharpeCompany annual report on formCambridge healthtech instituteGain therapeutics incExchange commission onExchange commissionLinnden communicationsMichaelj fox foundation for parkinson researchSilverstein foundation for parkinsonChief executive officerGain therapeuticsAnnual neurodegeneration targets conferenceDrug discoveryProgressive central nervous system

Gain Therapeutics (GANX) Receives Approval to Commence Phase 1 Clinical Study of GT-02287 from the Human Research Ethics Committee (HREC) in Australia

Gain Therapeutics (GANX) Receives Approval to Commence Phase 1 Clinical Study of GT-02287 from the Human Research Ethics Committee (HREC) in Australia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Matthias alderBellberry human research ethics committeeSilverstein foundation for parkinsonMichaelj fox foundation for parkinson researchGain therapeutics incMovement disordersInternational congressGain therapeuticsChief executive officerSilverstein foundation